Sorry! No results found
Please visit us back tomorrow as we add 10, 000 new research topics everyday!
About 10 results ( 0,39 seconds)
Having conceded ground to a number of its close rivals which gained considerable scale via large M&A activity (Pfizer, GlaxoSmithKline and Sanofi- Aventis), ...
... theme by which to classify infections caused by changes in cell membranes, according to Werner Kramer, Head of Metabolic Diseases at Sanofi-Aventis.
Among these are the boasts made by Sanofi-Aventis SA (SNY) to come by Chattem Inc. (CHTT) for $1.9 billion and Bucyrus International Inc. (BUCY) offer to ...
As of 2005, the five leading companies in terms of global sales were Pfizer with sales of $ 47.5 billion, GlaxoSmithKline with sales of $34.7 billion, Sanofi-Aventis ...
Pfizer, Sanofi-Aventis, Merck & Co ... becomes as such the largest lobby in Washington. Drawing a parallel with the very recent European registry of lobbyists ...
Sanofi-Aventis France 17?861 18?711 95.46% Roche Switzerland 17?460 25? 168 69.37% As Table 1.1 shows? the majority of the largest pharmaceutical ...
Its main competitors are GlaxoSmithKline, Pfizer, Procter & Gamble and Sanofi- Aventis (Johnson & Johnson, 2012). Discussion Challenges Faced by Johnson & ...